Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 22-Feb-24 8:06 PM View:  | Theravance Biopharma, Inc. (TBPH) | 20-Feb-24 | Payment of Exercise | 19,294 | $8.92 | $172,102.00 | (6%) 334.21K to 314.92K | (9%) |
| 22-Nov-23 6:10 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-23 | Payment of Exercise | 12,630 | $10.37 | $130,973.00 | (4%) 346.84K to 334.21K | 6% |
| 16-Nov-23 6:16 PM View: | Theravance Biopharma, Inc. (TBPH) | 14-Nov-23 | Market Sale (Planned) | 2,482 | $10.22 | $25,366.00 | (< 1%) 349.32K to 346.84K | 5% |
| 01-Nov-23 6:35 PM View: | Theravance Biopharma, Inc. (TBPH) | 30-Oct-23 | Grant | 15,000 | -- | -- | 4% 334.32K to 349.32K | |
| 18-Oct-23 6:54 PM View: | Theravance Biopharma, Inc. (TBPH) | 16-Oct-23 | Market Sale (Planned) | 2,482 | $9.03 | $22,412.50 | (< 1%) 336.8K to 334.32K | (8%) |
| 18-Sep-23 6:08 PM View: | Theravance Biopharma, Inc. (TBPH) | 14-Sep-23 | Market Sale (Planned) | 2,482 | $9.89 | $24,547.00 | (< 1%) 339.29K to 336.8K | 2% |
| 22-Aug-23 6:13 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-23 | Payment of Exercise | 10,461 | $9.70 | $101,472.00 | (3%) 349.75K to 339.29K | (< 1%) |
| 15-Aug-23 6:09 PM View: | Theravance Biopharma, Inc. (TBPH) | 11-Aug-23 | Market Sale (Planned) | 2,322 | $9.99 | $23,196.80 | (< 1%) 352.07K to 349.75K | 3% |
| 18-Jul-23 6:14 PM View: | Theravance Biopharma, Inc. (TBPH) | 14-Jul-23 | Market Sale (Planned) | 2,322 | $9.84 | $22,848.50 | (< 1%) 354.39K to 352.07K | 1% |
| 23-May-23 7:41 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-23 | Payment of Exercise | 10,460 | $11.21 | $117,257.00 | (3%) 367.17K to 356.71K | |
| 17-May-23 6:17 PM View: | Theravance Biopharma, Inc. (TBPH) | 15-May-23 | Private Sale (Planned) | 2,322 | $11.26 | $26,145.70 | (< 1%) 369.49K to 367.17K | |
| 18-Apr-23 5:49 PM View: | Theravance Biopharma, Inc. (TBPH) | 14-Apr-23 | Private Sale (Planned) | 2,323 | $11.88 | $27,597.20 | (< 1%) 371.82K to 369.49K | |
| 16-Mar-23 10:00 PM View: | Theravance Biopharma, Inc. (TBPH) | 14-Mar-23 | Market Sale (Planned) | 2,323 | $10.32 | $23,973.40 | (< 1%) 374.14K to 371.82K | 6% |
| 08-Mar-23 7:34 PM View: | Theravance Biopharma, Inc. (TBPH) | 06-Mar-23 | Market Sale (Planned) | 2,323 | $10.05 | $23,346.20 | (< 1%) 376.46K to 374.14K | 3% |
| 03-Mar-23 10:00 PM View: | Theravance Biopharma, Inc. (TBPH) | 01-Mar-23 | Grant | 75,000 | -- | -- | 25% 301.46K to 376.46K | |
| 22-Feb-23 7:21 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-23 | Payment of Exercise | 12,057 | $10.44 | $125,875.00 | (4%) 313.52K to 301.46K | 7% |
| 05-Dec-22 5:59 PM View: | Theravance Biopharma, Inc. (TBPH) | 01-Dec-22 | Private Sale | 2,084 | $10.73 | $22,361.30 | (< 1%) 315.6K to 313.52K | |
| 22-Nov-22 4:04 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-22 | Payment of Exercise | 27,350 | $10.85 | $296,748.00 | (8%) 342.95K to 315.6K | |
| 17-Nov-22 7:53 PM View: | Theravance Biopharma, Inc. (TBPH) | 16-Nov-22 | Payment of Exercise | 2,800 | $11.20 | $31,360.00 | (< 1%) 345.75K to 342.95K | |
| 23-Aug-22 6:57 PM View: | Theravance Biopharma, Inc. (TBPH) | 19-Aug-22 | Payment of Exercise | 18,991 | $9.34 | $177,376.00 | (5%) 364.75K to 345.75K | (4%) |
| 18-Aug-22 6:05 PM View: | Theravance Biopharma, Inc. (TBPH) | 16-Aug-22 | Market Sale | 4,906 | $9.71 | $47,639.70 | (1%) 369.65K to 364.75K | (< 1%) |
| 11-Aug-22 6:55 PM View: | Theravance Biopharma, Inc. (TBPH) | 09-Aug-22 | Market Sale | 15,086 | $8.79 | $132,606.00 | (4%) 384.74K to 369.65K | (11%) |
| 24-May-22 7:14 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-22 | Payment of Exercise | 3,947 | $8.74 | $34,496.80 | (1%) 388.68K to 384.74K | (11%) |
| 23-Feb-22 6:25 PM View: | Theravance Biopharma, Inc. (TBPH) | 18-Feb-22 | Payment of Exercise | 20,377 | $9.61 | $195,823.00 | (5%) 409.06K to 388.68K | (1%) |
| 06-Dec-21 7:51 PM View: | Theravance Biopharma, Inc. (TBPH) | 02-Dec-21 | Grant | 240,000 | -- | -- | 142% 169.06K to 409.06K | |
| 23-Nov-21 8:23 PM View: | Theravance Biopharma, Inc. (TBPH) | 19-Nov-21 | Payment of Exercise | 4,263 | $8.36 | $35,638.70 | (100%) 4.26K to 0 | (< 1%) |
| 24-Aug-21 6:52 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-21 | Payment of Exercise | 6,819 | $14.05 | $95,807.00 | (4%) 180.02K to 173.21K | (< 1%) |
| 24-May-21 6:09 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-21 | Payment of Exercise | 3,410 | $17.80 | $60,698.00 | (2%) 183.43K to 180.02K | 2% |
| 23-Feb-21 6:03 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-21 | Payment of Exercise | 6,597 | $18.79 | $123,958.00 | (3%) 188.75K to 182.15K | 4% |
| 10-Feb-21 6:30 PM View: | Theravance Biopharma, Inc. (TBPH) | 08-Feb-21 | Grant | 65,000 | -- | -- | 53% 123.75K to 188.75K | |
| 16-Dec-20 6:09 PM View: | Theravance Biopharma, Inc. (TBPH) | 14-Dec-20 | Market Sale | 7,500 | $19.47 | $146,058.00 | (6%) 131.25K to 123.75K | 4% |
| 24-Nov-20 6:14 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-20 | Payment of Exercise | 3,876 | $17.21 | $66,706.00 | (3%) 135.13K to 131.25K | (9%) |
| 03-Sep-20 6:10 PM View: | Theravance Biopharma, Inc. (TBPH) | 01-Sep-20 | Grant | 27,500 | -- | -- | 26% 107.63K to 135.13K | |
| 24-Aug-20 6:20 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-20 | Payment of Exercise | 6,598 | $18.22 | $120,216.00 | (6%) 114.22K to 107.63K | (3%) |